NGAL increases inflammatory states and its levels rise in arterial hypertension, obesity, diabetes, and metabolic complications such as insulin resistance, and is also involved in carcinogenesis. This evidence concerns the gene LCN2 and obesity due to melanocortin 4 receptor deficiency.